Developed to serve primarily as a litigation scouting report for plaintiff and defense counsel, insurers and legal service providers, HarrisMartin’s MDL Mass Tort & Class Action Monitor covers significant new filings and decisions in the JPML, MDL and related mass tort arenas. The quick delivery of breaking news and additional features will keep you within close range of every development occurring in the high-stakes environment of mass torts litigation — where minutes can make a difference. The MDL Mass Tort & Class Action Monitor is an online-only offering that includes frequent email updates and is available at no charge to annual and event sponsors of HarrisMartin’s CLE Conferences.
Download a publication order form here or subscribe here.
MDL Mass Tort & Class Action Monitor - Issue: 54
Valsartan MDL Defendants Urge Consideration of Alternative Drugs in TPP Damages Calculation
Valsartan MDL Judge Refuses to Lift Sanctions Against Defendant ZHP
Early Discovery Ordered on Issues of Diagnostic Testing, Preemption in GLP-RA MDL
SoClean Urges MDL Judge to Dismiss Philips’ False Advertising Counterclaims
MDL Mass Tort & Class Action Monitor - Issue: 53
Insurers Appeal Dismissal of South Korean Defendants from Hyundai/Kia Theft MDL
Tylenol MDL Judge Awards Defendants Summary Judgment on Remaining Claims
JPML Asked to Include Deep Vein Thrombosis Cases in GLP-1 RA MDL
Roundup Failure-To-Warn Claims Preempted by FIFRA, 3rd Cir. Rules
